Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Bergmann, L.; Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Grüllich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen, N. V.; Chevreau, C.; Negrier, S.; Depenbusch, R.; Cornelio, I.; Champsaur, A.; Escudier, B. J.; Pal, S. K.; Powles, T.; Choueiri, T. K. |
| Abstract Title: | Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 41 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2018 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2018-09-01 |
| Start Page: | 200 |
| End Page: | 201 |
| Language: | English |
| ACCESSION: | WOS:000446816500487 |
| PROVIDER: | wos |
| PUBMED: | 30261496 |
| DOI: | 10.1159/000492737 |
| Notes: | Meeting Abstract: P600 -- Source: Wos |
